Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

BACKGROUND: HPV is a major cancer-causing factor in both sexes in the cervix, vulva, vagina, anus, penis, oropharynx as well as the causal factor in other diseases such as genital warts and recurrent respiratory papillomatis. In the context of the arrival of a nonavalent HPV vaccine (6/11/16/18/31/3...

Descripción completa

Detalles Bibliográficos
Autores principales: Boiron, L., Joura, E., Largeron, N., Prager, B., Uhart, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833954/
https://www.ncbi.nlm.nih.gov/pubmed/27084683
http://dx.doi.org/10.1186/s12879-016-1483-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833954/
https://www.ncbi.nlm.nih.gov/pubmed/27084683
http://dx.doi.org/10.1186/s12879-016-1483-5

Ejemplares similares